Back to Search Start Over

Alembic Pharma's JV gets USFDA's nod for Desonide Ointment

Source :
Accord Fintech. October 24, 2019
Publication Year :
2019

Abstract

Desonide Ointment, 0.05%, has an estimated market size of $13 million for twelve months ending December 2018 Alembic Pharmaceuticals' joint venture (JV) Aleor Dermaceuticals (Aleor) has received approval from US [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Accord Fintech
Publication Type :
News
Accession number :
edsgcl.603610857